guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution [Obredon]

RxCUI: 1598284
RxNorm name: guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution [Obredon]
Display name: OBREDON (Oral Liquid)
Full name: guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution [Obredon]
Term type: SBD
Status: Active
Strength: 200-2.5 mg/5ml
Dose form: Sol
Route: Oral Liquid
Updated: 2026-10-15 14:52:05

RxNorm Status History#

Status: Active
Source: RXNORM
Current: YES
Release start: 022015
Active start: 022015
Multiple ingredient: YES
Branded: YES

Ingredients And Strength#

Ingredient, Strength, Base table
Ingredient	Strength	Base	Basis of strength
guaifenesin	40 MG / 1 ML	guaifenesin	guaifenesin
hydrocodone bitartrate	0.5 MG / 1 ML	hydrocodone	hydrocodone bitartrate

Dose Form Concepts#

Dose form, RxCUI table
Dose form	RxCUI
Oral Solution	316968

Derived Ingredient Concepts#

Ingredient, RxCUI table
Ingredient	RxCUI
guaifenesin	5032
hydrocodone	5489

Source Vocabulary Codes#

Code type, Values, Count table
Code type	Values	Count	Category
PRESCRIBABLE	Y	1	ATTRIBUTES
RXNAV_STR	Obredon (guaiFENesin 200 MG / HYDROcodone bitartrate 2.5 MG) per 5 ML Oral Solution	1	NAMES
RxNorm Name	guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution [Obredon]	1	NAMES
RxNorm Synonym	Obredon (guaifenesin 200 MG / hydrocodone bitartrate 2.5 MG) per 5 ML Oral Solution	1	NAMES
TTY	SBD	1	ATTRIBUTES
RxCUI	1598284	1	CODES
MMSL_CODE	BD8210	1	CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 4 matching rows.

NDC11, Source, Active table
NDC11	Source	Active
69166052316	rxnav_ndcs	yes
58716043304	rxnav_historical
58716043316	rxnav_historical
69166052304	rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set ID	Title	Manufacturer	Effective
f73fdec5-d330-4d8c-894b-d0bcf5490624	These highlights do not include all the information needed to use OBREDON ® safely and effectively. See full prescribing information for OBREDON. OBREDON (hydrocodone bitartrate and guaifenesin) oral solution CII Initial U.S. Approval: 2014	Sovereign Pharmaceuticals, LLC	20251017
f73fdec5-d330-4d8c-894b-d0bcf5490624	These highlights do not include all the information needed to use OBREDON ® safely and effectively. See full prescribing information for OBREDON. OBREDON (hydrocodone bitartrate and guaifenesin) oral solution CII Initial U.S. Approval: 2014	Sovereign Pharmaceuticals, LLC	20241014

Drug Classes#

Source, Class ID, Class table
Source	Class ID	Class	Type	Relationship	Drug concept
ATC	R05CA	Expectorants	ATC1-4		guaifenesin
ATC	R05DA	Opium alkaloids and derivatives	ATC1-4		hydrocodone
FDASPL	N0000193956	Expectorant	EPC	has_epc	guaifenesin
FDASPL	N0000175690	Opioid Agonist	EPC	has_epc	hydrocodone
FDASPL	N0000000174	Opioid Agonists	MOA	has_moa	hydrocodone
MEDRT	D006140	Guaifenesin	CHEM	has_ingredient	guaifenesin
MEDRT	D006853	Hydrocodone	CHEM	has_ingredient	hydrocodone bitartrate
MEDRT	D006853	Hydrocodone	CHEM	has_ingredient	hydrocodone
MEDRT	D001249	Asthma	DISEASE	ci_with	hydrocodone bitartrate
MEDRT	D001249	Asthma	DISEASE	ci_with	hydrocodone
MEDRT	D001991	Bronchitis	DISEASE	may_treat	guaifenesin
MEDRT	D003139	Common Cold	DISEASE	may_treat	guaifenesin
MEDRT	D003371	Cough	DISEASE	may_treat	hydrocodone bitartrate
MEDRT	D003371	Cough	DISEASE	may_treat	hydrocodone
MEDRT	D003371	Cough	DISEASE	may_treat	guaifenesin
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hydrocodone
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	hydrocodone bitartrate
MEDRT	D004342	Drug Hypersensitivity	DISEASE	ci_with	guaifenesin
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hydrocodone bitartrate
MEDRT	D007415	Intestinal Obstruction	DISEASE	ci_with	hydrocodone
MEDRT	D007827	Laryngitis	DISEASE	may_treat	guaifenesin
MEDRT	D008173	Lung Diseases, Obstructive	DISEASE	may_treat	hydrocodone bitartrate
MEDRT	D008173	Lung Diseases, Obstructive	DISEASE	may_treat	hydrocodone
MEDRT	D010612	Pharyngitis	DISEASE	may_treat	guaifenesin
MEDRT	D010149	Postoperative Pain	DISEASE	may_treat	hydrocodone
MEDRT	D010149	Postoperative Pain	DISEASE	may_treat	hydrocodone bitartrate
MEDRT	D012131	Respiratory Insufficiency	DISEASE	ci_with	hydrocodone
MEDRT	D012131	Respiratory Insufficiency	DISEASE	ci_with	hydrocodone bitartrate
MEDRT	D012221	Rhinitis, Allergic, Perennial	DISEASE	may_treat	guaifenesin
MEDRT	D012852	Sinusitis	DISEASE	may_treat	guaifenesin
MEDRT	D014917	Whooping Cough	DISEASE	may_treat	guaifenesin
MEDRT	N0000191866	Opioid mu-Receptor Agonists	MOA	has_moa	hydrocodone bitartrate
MEDRT	N0000191866	Opioid mu-Receptor Agonists	MOA	has_moa	hydrocodone
MEDRT	N0000175439	Analgesia	PE	has_pe	hydrocodone
MEDRT	N0000175439	Analgesia	PE	has_pe	hydrocodone bitartrate
MEDRT	N0000008501	Decreased Central Nervous System Organized Electrical Activity	PE	ci_pe	hydrocodone bitartrate
MEDRT	N0000008501	Decreased Central Nervous System Organized Electrical Activity	PE	ci_pe	hydrocodone
MEDRT	N0000008701	Decreased Medullary Respiratory Drive	PE	has_pe	hydrocodone bitartrate
MEDRT	N0000008701	Decreased Medullary Respiratory Drive	PE	has_pe	hydrocodone
MEDRT	N0000008768	Decreased Organized Electrical Activity	PE	has_pe	hydrocodone bitartrate
MEDRT	N0000008768	Decreased Organized Electrical Activity	PE	has_pe	hydrocodone
MEDRT	N0000008867	Decreased Respiratory Secretion Viscosity	PE	has_pe	guaifenesin
MEDRT	N0000009560	Increased Respiratory Secretions	PE	has_pe	guaifenesin

Group, Type, Concept table
Group	Type	Concept	Source
BN	BN	Obredon	rxnav_allrelated
DF	DF	Oral Solution	rxnav_allrelated
DFG	DFG	Oral Liquid Product	rxnav_allrelated
DFG	DFG	Oral Product	rxnav_allrelated
IN	IN	guaifenesin	rxnav_allrelated
IN	IN	hydrocodone	rxnav_allrelated
MIN	MIN	guaifenesin / hydrocodone	rxnav_allrelated
PIN	PIN	hydrocodone bitartrate	rxnav_allrelated
SBD	SBD	guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution [Obredon]	rxnav_allrelated
SBDC	SBDC	guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML [Obredon]	rxnav_allrelated
SBDF	SBDF	guaifenesin / hydrocodone Oral Solution [Obredon]	rxnav_allrelated
SBDFP	SBDFP	guaifenesin / hydrocodone bitartrate Oral Solution [Obredon]	rxnav_allrelated
SBDG	SBDG	Obredon Oral Liquid Product	rxnav_allrelated
SBDG	SBDG	Obredon Oral Product	rxnav_allrelated
SCD	SCD	guaifenesin 40 MG/ML / hydrocodone bitartrate 0.5 MG/ML Oral Solution	rxnav_allrelated
SCDC	SCDC	guaifenesin 40 MG/ML	rxnav_allrelated
SCDC	SCDC	hydrocodone bitartrate 0.5 MG/ML	rxnav_allrelated
SCDF	SCDF	guaifenesin / hydrocodone Oral Solution	rxnav_allrelated
SCDFP	SCDFP	guaifenesin / hydrocodone bitartrate Oral Solution	rxnav_allrelated
SCDG	SCDG	guaifenesin / hydrocodone Oral Liquid Product	rxnav_allrelated
SCDG	SCDG	guaifenesin / hydrocodone Oral Product	rxnav_allrelated
SCDGP	SCDGP	guaifenesin / hydrocodone bitartrate Oral Liquid Product	rxnav_allrelated
SCDGP	SCDGP	guaifenesin / hydrocodone bitartrate Oral Product	rxnav_allrelated

Properties#

Category, Property, Value table
Category	Property	Value
ATTRIBUTES	AVAILABLE_STRENGTH	40 MG/ML / 0.5 MG/ML
ATTRIBUTES	GENERAL_CARDINALITY	MULTI
ATTRIBUTES	HUMAN_DRUG	US
ATTRIBUTES	RXNAV_HUMAN_DRUG	US
NAMES	Prescribable Synonym	Obredon 2.5 MG / 200 MG in 5 mL Oral Solution
NAMES	Tallman Synonym	guaiFENesin 40 MG/ML / HYDROcodone bitartrate 0.5 MG/ML Oral Solution [Obredon]
NAMES	Tallman Synonym	Obredon (guaiFENesin 200 MG / HYDROcodone bitartrate 2.5 MG) per 5 ML Oral Solution
SOURCES	Source	Gold Standard Alchemy